Immunogenicity and safety of SARS-CoV-2 vaccine with immunosuppressive agents.

Koichi KameiMasao OguraMai SatoKentaro NishiKensuke Shoji Takanori FunakiChikara OgimiShuichi Ito

Published in: Pediatrics international : official journal of the Japan Pediatric Society (2022)

SARS-CoV-2 mRNA vaccine was immunogenic in children and adolescents taking immunosuppressive agents, although SOT recipients and patients taking two immunosuppressive agents tended to show lower postvaccination antibody titers.

Keyphrases

sars cov
end stage renal disease
respiratory syndrome coronavirus
newly diagnosed
ejection fraction
chronic kidney disease
peritoneal dialysis
prognostic factors
coronavirus disease